
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a China-based company in the Healthcare sector with a market capitalisation of $6.4B. Its FinScore is 68/100; its highest-scoring layer is Quality (74) and its lowest is Growth (51). The shares trade at 13.5x trailing earnings and are down 11% year to date.
Share price performance
About China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
www.999.com.cnChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- China
- Fiscal year-end
- December
- Trading currency
- CNY
- Reporting currency
- CNY
- Fundamentals updated
- 64 days ago
- Market cap
- $6.4B
- Shares outstanding
- 1.7B
- P/E (TTM)
- 13.5x
- Dividend yield (TTM)
- 3.93%
- Beta (issuer)
- 0.09
- Revenue (latest FY)
- CN¥31.6B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.